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ABSTRACT 
Phosphofructokinase (E.C.2.7.1.11) is an ambiquitous enzyme; ie it can 
be located either in a cytosolic or particulate form, depending on the 
metabolic status of the cell. Two indepedent methods were used to 
attempt to determine the particulate location of sheep heart PFK . 
The first method involved an adaptation of the method of subcellular 
fractionation of liver, for use with heart tissue. A crude 
fractionation procedure was first used, in which the PFK was found to 
be located in a fraction which precipitated at 800g. Specific enzyme 
assays of acid phosphatase, succinic dehydrogenase and 5'-
nucleotidase , were performed to determine the presence of lysosomes, 
mitochondria and plasma membrane respectively, in the fraction 
containing PFK. These assays revealed that most of the enzyme 
activity corresponding to the above organelles, had also precipitated 
in this fraction. Both mitochondria and myofibrils were purified to 
determine if PFK copurified with these organelles, but the results 
obtained were inconclusive . 
The second method involved immunochemical localisation of PFK. 
Antibodies against purified sheep heart PFK were raised in rabbits, 
and an attempt was made to separate the anti-sheep heart PFK 
antibodies from the other antibodies by affinity chromatography. Both 
CD I - activated and cyanogen bromide activated sepharose columns were 
made and used. Successful separation was not achieved. Western 
blotting followed by staining with a second antibody labelled with 
alkaline phosphatase, revealed that the antibody preparation was 
sufficiently specific to proceed to immunochemical localisation. 
Sections of fresh sheep heart were embedded at low temperature in 
Lowicryl K4M resin, then incubated with the anti-sheep heart 
antibodies followed by secondary antibodies labelled with 15nm gold 
particles. Electron micrographs of the sections revealed the electron 
dense gold particles, and hence the location of the PFK. 
By comparing the density of gold particles on the myofibrils with that 
of the background it was shown that the density on myofibrils was 4 to 
4. 5 times higher than on the background. Thus it was tentatively 
shown that the myofibrils was the site of localisation of PFK in s heep 
heart cells. 
Investigations into the effect of metabolites on the solubilisation of 
PFK from the membrane , by including various salts in the extraction 
buffer, revealed that divalent anions, specif ically sulphite, sulphate 
and thiosulphate ions , were effective in releasing PFK into the 
cytosol. The effect of fructose-2, 6-bisphosphate on the 
solubilisation and activity o f sheep heart PFK was uncertain, but it 
appeared to inhibit the activity of cytosolic PFK and have no effect 
on the solubilisation . 
The possible cross reactivity of the anti - sheep heart antibodies with 
other sheep tissues and species was studied via polyacrylamide gel 
electrophoresis of immunoprecipitates, Micro - Ouchterlony plates and 
alkaline phosphatase staining of Western Blots. Cross reactivity was 
observed with sheep muscle and to a less extent, rat heart. Only 
minor cross reactivity was observed against liver PFK (rat or sheep), 
though this may be due to low levels of PFK in that tissue . 
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CHAPTER 1 GENERAL INTRODUCTION 
Glycolysis has two main roles. The first is the degradation of 
glucose in order to generate ATP, and the second is to provide carbon 
skeletons for synthetic reactions. The process of glycolysis needs to 
be regulated to suit the needs of the cell for these components. 
Those enzymes which catalyse reactions which are virtually 
irreversible, tend to play a regulatory as well as catalytic function 
in biochemical pathways , and in glycolysis these enzymes are 
hexokinase (E.C.2.7.1.1), phosphofructokinase (E.C.2.7 . 1 . 11) and 
pyruvate kinase (E.C . 2 . 7 . 1.40) . 
The most important regulatory enzyme in the glycolytic pathway, is 
phosphofructokinase (PFK), which catalyses the phosphorylation of 
fructose-6-phosphate to fructose-1,6-bisphosphate with the concomitant 
dephosphorylation of ATP to ADP. PFK, rather than hexokinase , is the 
main glycolytic control enzyme because it regulates the committing 
step of glycolysis. Glucose-6-phosphate can be used in glycogen 
synthesis, or oxidised by the pentose phosphate pathway as well as be 
converted to pyruvate . The conversion of f ructose - 6 -phosphate to 
fructose - 2, 6-bisphosphate however , commits the 6 carbon skeleton to 
glycolytic catabolism . 
The Discovery and Structure of PFK 
PFK was first identified in 1935 by Dische (Dische , 1935), after it 
had been shown that the phosphorylation of fructose - 6- phosphate to 
fructose - 2, 6- bisphosphate was an essential reaction of glycolysis in 
yeast (Harden and Young, 1908; Young, 1909). PFK was later identified 
in animal tissues (Ostern et al , 1936) and in plant tissue (Axelrod et 
al , 1952) . 
2 
Catalytically act ive ma mmalia n PFK is a tetramer of molecular weight 
320 , 000 to 360 , 000 , (Aaronson and Frieden, 1972; Mansour , 1972) , 
although polymers of up to 2xl0 6 have been reported (Mansour , 1970) . 
Brennan et al (1974) determined a range of molecular weights of sheep 
heart PFK protomers of 80 , 000 to 85 , 000 by SDS gel electrophoresis. 
Peptide mapping o f tryptic peptides was cons is tent with a 85 , 000 
molecular weight form composed of identical subunits. Preliminary 
sequencing by Walker et al (1976) lead to the conclusion that rabbit 
muscle PFK was a tetrame r ic enzyme consisting of four similar 
(probably identical) subunits with a molecular weight of 85,000, and 
to the proposal that gene duplication could have occurred in the 
evolution of eukaryotic PFKs . 
Rabbit skeletal muscle PFK and sheep heart PFK undergo association-
di ssoc ia tion reactions to catalytically active and inactive forms 
(Mansour and Ahlfors , 1968; Aaronson and Frieden, 1972); the active 
form being the polymer and the inactive form the dimer. Strong 
activators such as fructose-2 , 6 - bisphosphate and fructose - 1 , 6 -
bisphosphate stabilise the tetramer, whereas inhibitors such as 
citrate, depolymerise the active tetramer to i n active dimers . 
Fructose-6-phosphate modulates the effect of citrate by stabilising a 
mixture of aggregates of intermediate size and activity (Lad et al, 
1973) . 
PFK is more active in those tissues with a high rate of glycolysis 
such as muscle and brain, rather than gluconeogenic tissues such as 
liver (Brock , 1969). However , reg a rd less of its source P FK is 
controlled by the same allosteric effectors (Lowry and Passonneau, 
19 64) . When cellular energy is low (indicated by a low ATP/AMP 
ratio) , or the availability of cellular building blocks is limited 
(indi cated by low citrate levels) , then PFK is activated. If the cell 
is r i ch in energy and carbon skeletons (high ATP/AMP ratio and high 
citra te levels) , then PFK is inactivated . 
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ATP is a potent inhibitor of PFK activity below pH7. 5 and at low 
fructose - 6- phosphate concentrations . The ATP - inactivated enzyme can 
be reactivated b y cyclic 3 ', 5 ' - AMP , 5 ' -AMP , ADP and ino r ganic 
phosphate , since these compounds antagonize this inhibition. ATP 
inhibition and cyclic AMP reactivation are not observed at high 
fructose-6-phosphate concentrations , or at an alkaline pH . (Mansour, 
19 63; Mansour , 1965). A review of the strucure and function of PFK is 
presented by Goldhammer and Dies (1979). 
Regulation by pH Induced Dimerisation 
Both Trevedi and Danforth (1966) and Ui (1966) independently 
demonstrated in vitro , the suppression of PFK activity as the assay pH 
was lowered . They suggested that this PFK inhibition was the cause of 
pH-induced glycolytic inhibition . 
Bock and Frieden (1974) demonstrated the reduction of PFK activity in 
rabbit skeletal muscle as the pH was lowered. They later (Frieden et 
al, 1976a,b, and c) studied the kinetics of inactivation and 
reactivation as a function of pH and enzyme concentration at constant 
temperature . From the enzyme concentration dependence they concluded 
that the mechanism involved at least a protonation step followed by 
isomerisation to an inactive form , and then dissociation into a 
species one half the molecular weight . Ionisable groups control the 
inactivation process and the appa r ent pK for these groups is 
temperature dependent so that the enzyme is cold labile below pH 7 . 0 . 
Reactivation of the inactive enzyme occurs by a kinetically different 
pathway . The inactive , dissociated form is protonated to a form which 
may either isomerise to another inactive form, or dimerise to the 
active enzyme. Frieden et al , (1976a , b and c) , postulated a mechanism 
containi ng four species (two with four subunits and two with two 
subunits), each of which can be protonated or unprotonated. 
Inactivation or reactivation is induced by changes in pH or 
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temperature. They also concluded that substrates and allosteric 
effectors exert their effect on pH - dependent inactivation by binding 
preferentially to either t he protonated or unprotonated forms, and 
thus shifting the apparent pK for the process . 
Hand and Somero (1983) showed that the acidification which occurs when 
squirrels enter hibernation , acting synergistically with a fall in 
body temperature, promotes PFK inhibition . They showed that the loss 
of activity was due to a freely reversible conversion of the active, 
tetrameric form of the enzyme to the catalytically inactive , but 
structurally active, dimeric form of PFK, as proposed by Bock and 
Frieden (1976a,b and c) . When the squirrels return to their euthermic 
state the tetrameric form is restored. Hand and Somero (1984) in a 
similar study to the above on thornbacked rays, showed that t he 
particulate form of PFK had a marked reduction in pH induced 
sensitivity compared with the soluble form. They believed this 
reduced sensitivity may have been due to an aggregation of monomers. 
This particulate PFK non-sensitivity was demonstrated only in vitro 
however. 
Hand and Carpenter (1986a and b) , 
inactivation of PFK in is chemic 
showed reversible dissociation and 
rat hearts , and decided that the 
enzyme dissociation represented dimerisation of PFK tetramers, rather 
than dissociation into four protomers. This suggestion was based on 
several pieces of evidence. The sedimentation value for the inactive 
form was consistent with that of a two protomer species (80 , 000-90 , 000 
Mwt each), and the dimer-dimer contact site appeared to be hydrophobic 
as compared with the protomer- protomer contact which is ionically 
bonded. Thirdly , both the inactive and active forms were 
immunoprecipitable, whereas PFK protomers are not. Hand and Carpenter 
(1986a and b) also showed that certain metabolites, such as fructose-
2 , 6-bisphosphate, stabilized the enzyme against pH-induced 
dimerisation . Citric acid, on the other hand, enhances the 
inactivation process. 
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Regulation of PFK by Phosphorylation - Dephosphorylation 
Incorporation studies by Brand and Soling (1975), showed that rat 
liver PFK was activated by a kinase catalysed phosphorylation, and 
inactivated by a phosphatase catalysed dephosphorylation . Brand and 
Soling (1976), also showed that in vivo, both active and inactive 
forms of PFK exist, and that the proportion of the two forms depends 
on the nutritional state of the animal. The sum of the two forms, 
however, remains constant. Hofer and Furst (1976) , isolated the 
phosphorylated form of PFK from rabbit skeletal muscle and suggested 
that a possible role of the phosphate residue may be as an 
interconversion mechanism . 
Tryptic digestion of the phosphorylated PFK, removed a peptide of less 
than 30 amino acids from the carboxyl terminus. This peptide 
contained a phosphoserine. It was found that the susceptibility of 
the terminal region to proteolysis was dependent on the conformational 
state of the enzyme 
found that rabbit 
(Riquelme and Kemp, 1980) Kemp et al (1981) , 
skeletal muscle PFK was phosphorylated by the 
catalytic subunit of a cyclic AMP dependent protein kinase , and that 
the rate of phosphorylation was increased in the presence of 
allosteric activators eg AMP, and decreased in the presence of 
inhibitors eg ATP. The activators and inhibitors alter the Vmax of 
phosphorylation but not the ~ - Kemp et al (1981) also determined 
that the exact site of phosphorylation was a serine residue, six amino 
acid residues from the carboxyl terminus. 
The question of whether or not phosphorylation-dephosphorylation of 
PFK does actually play a regulatory role is debatable . Furuya and 
Uyeda (1980) suggest that the degree of phosphorylation determines the 
binding of activators and hence the activity of PFK would be directly 
controlled by intracellular metabolite levels. Since phosphorylated 
PFK is more susceptible to proteolysis (Riquelme and Kemp , 1980), 
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phosphorylation-dephosphorylation may act to limit the levels of 
activated PFK. Soling and Brand (1981), in their review of the 
covalent modification of PFK by phosphorylation-dephosphorylation 
suggest the possibility that PFK phosphorylation is involved in the 
spatial arrangement of the enzyme within the cell. Luther and Lee 
(1986) believe that phosphorylated PFK has a higher affinity for F-
actin than the dephosphorylated form. They found that upon muscle 
contraction the enzyme become more phosphorylated and binding to the 
muscle ma tr ix increased. However, the experimental evidence of 
Riquelme et al (1978), and Kemp and Foe (1983), suggests that 
phosphorylation has little effect on enzyme activity. 
Intracellular Distribution as a Regulatory Mechanism 
Until recently, research into enzyme-structure interactions ha s b een 
limited to those enzymes which are strongly bound or integral 
components of membranes, and those which a re compartmentalised in 
subcellular organelles. However, over recent years there has been 
study and discussion on the possibility of cytosolic enzymes 
interacting with the cell matrix, or being organised into multi-enzyme 
complexes. 
Historically, the study of interactions between cytosolic components 
and cellular structure can be traced back to the investigations of 
Green et al (1965). Green and his co-workers described membrane 
fractions derived from erythrocytes and yeast cells, which were 
capable of catalysing glycolysis and put forward the postulate that 
all metabolic sequences may be membrane bound. 
John E . Wilson coined the term 'ambiquitous' to describe those enzymes 
'whose distribution bet ween soluble and particulate forms may vary 
with the metabolic status of the cell as reflected in the levels of 
certain metabolites capable of influencing that distribution' (Wilson, 
1978) . 
7 
Brain hexokinase is the prototype ambiquitous enzyme (Wilson, 1980) . 
Association of hexokinase with brain mitochondria was first reported 
many years ago by Crane and Sols (1953) and Johnson (1960). They 
found that about 80% of the total hexokinase activity in brain 
homogenates was particulate. Rose and Warms (1967) found that the 
mitochondria-bound enzyme could be solubilised by the addition of 
glucose - 6-phosphate or ATP. Wilson (1968) reported that a change in 
soluble-particulate distribution was a factor in the regulation of 
hexokinase activity in vivo. Brain hexokinase has been shown to 
definitely exhibit ambiquitous behaviour in vivo, by Knull et al 
(1973, 1974) in their study of chick and mouse brains . Their data 
indicated that an increased glycolytic rate 
insulin treatment resulted in a rapid and 
increased proportions o f the particulate enzyme. 
due to ischaemia or 
reversible shift to 
Felgner et al (1979 ) 
have isolated a protein from the outer mitochondrial membrane, which 
they believe is the binding site for hexokinase. 
Aldolase is another ambiquitous enzyme which has been well studied. 
Arnold and Pette (1968) first noted that aldolase bound to the 
particulate fraction in rabbit muscle. In rat brain it was found that 
one isoenzyme of aldolase preferentially bound to the microsomes, 
whereas another isoenzyme was located primarily in the cytosol (Clarke 
et al, 1970). Since then aldolase has been shown to bind to F-actin 
and troponin-tropomyosin complexes in bovine and rabbit muscle (Arnold 
and Pette, 1970; Arnold et al, 1971; Clarke et al, 1974; Morton et al, 
1977). Walsh et al (1977) showed that the binding of aldolase to F-
actin-tropomyosin-troponin filaments produced major alterations in the 
kinetic parameters of aldolase. Aldolase has also been shown to bind 
to other cell components depending on the tissue being studied. Using 
immunohistochemical techniques, Foemmel et al (1975) demonstrated the 
association of aldolase with endoplasmic reticulum, and Strapazon and 
Steck (1976, 1977) have shown that rabbit muscle aldolase binds to 
Band 3, the predominant polypeptide of the human erythrocyte membrane. 
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Aldolase can be specifically released from the membrane by relatively 
low levels of its substrate, fruct ose-1,6-bisphosphate, but not by any 
other common metabolite (Arnold and Pette , 1970; Strapazon and Steck, 
1977) . 
In 1974, Craven and Basford found that PFK bound to purified rat brain 
mitochondria in the presence of ADP, and to a certain extent in the 
presence of ATP. Inorganic phosphate had a slight effect on the 
solubilisation of PFK, whereas fructose-6 - phosphate had no effect. 
Later Karadsheh and Uyeda (1977) noted a specific interaction between 
PFK and the inner surface of erythrocyte membrane, and that this 
binding to the membrane was associated with a change in the allosteric 
properties of the enzyme. The membrane bound enzyme was apparently 
not inhibited by ATP or 2, 3- diphosphoglycerate, and its fructose-6 -
phosphate curve reverted to a non-sigmoidal shape . It seemed that t he 
interac tion had reduced the conformational flexibility of the enzyme . 
Their results implied that the regulatory role of PFK may be 
influenced by adsorption to cellular structure. Jenkins et al (1985), 
showed that the polyacidic amino- terminal sequence of Band 3 of 
erythrocyte membranes, bound electrostatically to the polybasic 
adenine nucleotide-activation site of PFK. ADP and NADH displaced PFK 
from the membrane by binding to this adenine nucleotide activation 
site. From their results , it was concluded that Band 3 protein binds 
PFK dimers with a higher affinity than the tetramers, thus shifting 
the cytosolic tetramer- dimer equilibrium towards the inactive dimer, 
and so resulting in a decrease in PFK activity. 
By applying subcellular 
homogenates, Choate et al 
associated with myofibrils. 
fractionation techniques to sheep heart 
(1985), showed that PFK appeared to be 
Their results also indicated that PFK 
binding to the particulate fraction was enhanced when the pH was 
lowered, and solubilised by increased pH or ATP concentrations. 
Choate et a l suggested that the shifting of the equilibrium of PFK 
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from soluble to particulate may be a mechanism to regulate PFK 
activity. Binding to the particulate fraction during acidosis may 
prevent irreversible inactivation of the enzyme, and ensure continued 
production of fructose-1,6-bisphosphate. 
The main aim of this thesis is to determine the particulate location 
of PFK by two independent means. The first method involved adapting 
the subcellular fractionation techniques used for liver tissue 
(Fleischer and Kervina, 1974), for use with sheep heart. Once the 
range of possible locations for PFK have been narrowed by crude cell 
fractionation, the location could be pinpointed by more refined 
fractionation methods. Procedures for heart fractionation are not as 
well developed as those for liver, but sheep heart was chosen for 
study, since large supplies of highly purified sheep heart PFK could 
be readily obtained. Having a supply of pure PFK was essential for 
the second part of the study, in which antibodies specific against 
sheep heart PFK are raised, for use in determining the location of PFK 
by Immunogold Localisation and Electron Microscopy (Robertson et al, 
1985) . 
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